A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)

Regulatory Toxicology and Pharmacology

Volumn 71, Issue 2, 2015, Pages S1-S27

  Arts, Josje H E ^a   Hadi, Mackenzie ^b   Irfan, Muhammad Adeel ^c   Keene, Athena M ^d   Kreiling, Reinhard ^e   Lyon, Delina ^f   Maier, Monika ^g   Michel, Karin ^h   Petry, Thomas ⁱ   Sauer, Ursula G ^j   Warheit, David ^k   Wiench, Karin ^c   Wohlleben, Wendel ^c   Landsiedel, Robert ^c  

^a AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

^b SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^c BASF SE   (Germany)

^d AFTON CHEMICAL CORPORATION   (United States)

^e CLARIANT PRODUKTE DEUTSCHLAND GMBH   (Germany)

^f SHELL OIL COMPANY   (United States)

^g EVONIK DEGUSSA GMBH   (Germany)

^h HENKEL KGAA   (Germany)

ⁱ ToxMinds Consultants   (Belgium)

^j Animal Welfare Academy   (Germany)

^k DUPONT COMPANY   (United States)

more..

Author keywords

Apical toxic effects; Biodistribution; Biopersistence; Cellular effects; Grouping; Intrinsic material properties; Nanomaterials; Read across; Risk assessment; System dependent properties

Indexed keywords

NANOMATERIAL; POLLUTANT;

ARTICLE; BIOPERSISTENCE; CLASSIFICATION; DECISION MAKING; DISPERSIBILITY; DISSOLUTION; ENVIRONMENTAL EXPOSURE; GASTROINTESTINAL ABSORPTION; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; HYDROPHOBICITY; LIFE CYCLE ASSESSMENT; LUNG CLEARANCE; MATERIALS TESTING; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN ABSORPTION; SOLUBILITY; SURFACE AREA; SURFACE CHARGE; SURFACE CHEMISTRY; SURFACE PROPERTY; SURFACE REACTIVITY; SUSTAINABLE DEVELOPMENT; TOXICITY TESTING; ANIMAL; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; EUROPE; LEGISLATION AND JURISPRUDENCE; POLLUTANT; STANDARDS; TOXICITY;

ANIMALIA;

ANIMALS; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; EUROPE; HUMANS; NANOSTRUCTURES; PARTICLE SIZE; TOXICITY TESTS;

EID: 84931566361     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.03.007     Document Type: Article

References (198)

1. Aalapati S., Ganapathy S., Manapuram S., Anumolu G., Prakya B.M. Toxicity and bio-accumulation of inhaled cerium oxide nanoparticles in CD1 mice. Nanotoxicology 2014, 8:786-798.
2. Aillon K.L., Xie Y., El-Gendy N., Berkland C.J., Forrest M.L. Effects of nanomaterial physico-chemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61:457-466.
3. Alkilany A.M., Murphy C.J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?. J. Nanopart. Res. 2010, 12:2313-2333.
4. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29:730-741.
5. Arts J.H.E., Muijser H., Duistermaat E., Junker K., Kuper C.F. Repeated (5-day) inhalation toxicity of three types of synthetic amorphous silicas in Wistar rats: evaluation of their toxicity up to 3months after exposure. Food Chem. Toxicol. 2007, 45:1856-1867.
6. Arts J.H.E., Hadi M., Keene A.M., Kreiling R., Lyon D., Maier M., Michel K., Petry T., Sauer U.G., Warheit D., Wiench K., Landsiedel R. A critical appraisal of existing concepts for the grouping of nanomaterials. Regul. Toxicol. Pharmcol. 2014, 70:492-506.
7. ASTM, undated. American Society for Testing and Materials Standard D3053 on Terminology Relating to Carbon Black. see: doi: 10.1520/D3053.
8. Baer D.R., Gaspar D.J., Nachimuthu P., Techane S.D., Castner D.G. Application of surface chemistry analysis tools for characterization of nanoparticles. Anal. Bioanal. Chem. 2010, 396(3):963-1002.
9. Ball N., Bartels M., Budinsky R., Klapacz J., Hays S., Kirman C., Patlewicz G. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study. Regul. Toxicol. Pharmacol. 2014, 68(2):212-221.
10. BAuA, 2013. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Bekanntmachung zu Gefahrstoffen. Hergestellte Nanomaterialien. - German Federal Institute for Occupational Safety and Health. Announcement regarding hazardous substances. Manufactured nanomaterials. BekGS 527. BMBl (Nr. 25). pp. 498-511 http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/Bekanntmachung-527.html.
11. BAuA, 2014a. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Technische Regel für Gefahrstoffe 905. Verzeichnis krebserzeugender, erbgutverändernder oder fortpflanzungsgefährdender Stoffe. - German Federal Institute for Occupational Safety and Health. Technical rule regarding hazardous substances. Register of carcinogenic, mutagenic or toxic to reproduction substances. GMBl 2013, 510-522 http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/TRGS-905.html.
12. BAuA, 2014b. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Begründung zum Allgemeinen Staubgrenzwert (2014/2001) in TRGS 900, Arbeitsplatzgrenzwerte, Nr. 12 GMBl 2014, 271, Bek. d. BMAS v. 14.2.2014. IIIb 3, 35125 - 5. In: Bekanntmachung von Technischen Regeln - Justification of the general dust limit in the technical rule on hazardous substances 900 (occupational exposure limits Nr. 12) http://www.baua.de/cae/servlet/contentblob/664342/publicationFile/47939/900-allgemeiner-%20staubgrenzwert.pdf.
13. Bello D., Hsieh S.-F., Schmidt D., Rogers E. Nanomaterials properties versus biological oxidative damage: implications for toxicity screening and exposure assessment. Nanotoxicology 2009, 3:249-261.
14. Braakhuis H.M., Park M.V., Gosens I., De Jong W.H., Cassee F.R. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part. Fibre Toxicol. 2014, 11(1):18.
15. Bräu M., Ma-Hock L., Hesse C., Nicoleau L., Strauss V., Treumann S., Wiench K., Landsiedel R., Wohlleben W. Nanostructured calcium silicate hydrate seeds accelerate concrete hardening: a combined assessment of benefits and risks. Arch. Toxicol. 2012, 86:1077-1087.
16. Brown D.M., Wilson M.R., MacNee W., Stone V., Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 2001, 175:191-199.
17. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., Bruinink A., Stark W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40(14):4374-4381.
18. BSI, 2007. British Standards Institute. Nanotechnologies - Part 2: Guide to safe handling and disposal of manufactured nanomaterials. PD 6699-2:2007. ISBN 978 0 580 60832 2.
19. 4 nanomaterials with or without surface functionalization upon 28-day oral exposure to rats. Arch. Toxicol. 2014, 88:1881-1906.
20. Burello E., Worth A.P. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 2011, 5(2):228-235.
21. Chen R., Zhang Y., Darabi Sahneh F., Scoglio C.M., Wohlleben W., Haase A., Monteiro-Riviere N.A., Riviere J.E. Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling. ACS Nano 2014, 8(9):9446-9456.
22. Cho W.S., Kang B.C., Lee J.K., Jeong J., Che J.H., Seok S.H. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 2013, 10:9.
23. Choi H.S., Ipe B.I., Misra P., Lee J.H., Bawendi M.G., Frangioni J.V. Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett. 2009, 9(6):2354-2359.
24. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., Bawendi M.G., Semmler-Behnke M., Frangioni J.V., Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010, 28(12):1300-1303.
25. Chusuei C.C., Wu C.H., Mallavarapu S., Hou F.Y., Hsu C.M., Winiarz J.G., Aronstam R.S., Huang Y.W. Cytotoxicity in the age of nano: the role of fourth period transition metal oxide nanoparticle physicochemical properties. Chem. Biol. Interact. 2013, 206(2):319-326.
26. Cohen J.M., Teeguarden J.G., Demokritou P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part. Fibre Toxicol. 2014, 11:20.
27. Colognato R., Park M.V.D.Z., Wick P., De Jong W.H. Interactions with the human body. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology and Impact on Human Health 2012, Elsevier, Amsterdam. B. Fadeel, A. Pietroiusti, A.A. Shvedova (Eds.).
28. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J.A.M., Geertsma R.E. Particle size dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
29. DeLoid G., Cohen J.M., Darrah T., Derk R., Rojanasakul L., Pyrgiotakis G., Wohlleben W., Demokritou P. Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat. Commun. 2014, 5:3514.
30. Delorme M.P., Muro Y., Arai T., Banas D.A., Frame S.R., Reed K.L., Warheit D.B. Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats. Toxicol. Sci. 2012, 128(2):449-460.
31. Docter D., Bantz C., Westmeier D., Galla H.J., Wang Q., Kirkpatrick J.C., Nielsen P., Maskos M., Stauber R.H. The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles. Beilstein J. Nanotechnol. 2014, 5:1380-1392.
32. Donaldson K., Aitken R., Tran L., Stone V., Duffin R., Forrest G., Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 2006, 92:5-22.
33. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol. 2010, 7:5.
34. Donaldson K., Murphy F., Schinwald A., Duffin R., Poland C.A. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine 2011, 6:143-156.
35. Donaldson K., Poland C.A. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr. Opin. Biotechnol. 2013, 24:724-734.
36. Dowding J.M., Das S., Kumar A., Dosani T., McCormack R., Gupta A., Sayle T.X.T., Sayle D.C., von Kalm L., Seal S., Self W.T. Cellular interaction and toxicity depend on physico-chemical properties and surface modification of redox-active nanomaterials. ACS Nano 2013, 7(6):4855-4868.
37. Driscoll K.E., Costa D.L., Hatch G., Henderson R., Oberdörster G., Salem H., Schlesinger R.B. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sci. 2000, 55(1):24-35.
38. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007, 19(10):849-856.
39. Duncan T.V., Pillai K. Release of engineered nanomaterials from polymer nanocomposites: diffusion, dissolution and desorption. ACS Appl. Mater. Interfaces 2015, 7(1):2-19.
40. ECETOC. 2013. TR 122. Poorly soluble particles. Lung overload. December 2013.
41. ECHA, 2008. Guidance on information requirements and chemical safety assessment. Chapter R.6. QSARs and grouping of chemicals. European Chemicals Agency. p. 134 http://echa.europa.eu/documents/10162/13632/information_requirements_r6_en.pdf.
42. Assessment of read-across in REACH 2012, ECHA, European Chemicals Agency, p. 58.
43. ECHA, 2012b. Background Paper. An introduction to the assessment of read-across. Experts workshop on read-across assessment with the active support of Cefic LRI. 2-3 Oct 2012. European Chemicals Agency. p. 8 http://echa.europa.eu/documents/10162/5649897/ws_raa_20121003_background_paper_an_introduction_to_the_assessment_of_read-across_in_echa_en.pdf.
44. ECHA, 2012c. Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific guidance. European Chemicals Agency ECHA-12-G-03-EN, Apr 2012. p. 60 http://echa.europa.eu/documents/10162/13632/appendix_r7a_nanomaterials_en.pdf.
45. ECHA, 2013. Grouping of substances and read-across approach. Part I. Introductory note. European Chemicals Agency ECHA-13-R-02-EN, Apr 2013. p. 11.
46. ECHA, 2014. Human health and environmental exposure assessment and risk characterization of nanomaterials. Best practice for REACH registrants. Third GAARN meeting - Helsinki, 30 Sep 2013. ECHA-14-R-10-EN. p. 12.
47. European Food Safety Authority. EFSA guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J. 2011, 9(5):2140. EFSA.
48. EP and Council of the EU, 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396/1, 30 Dec 2006.
49. EP and Council of the EU 2008. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. OJ L 353/1, 31 Dec 2008.
50. EP and Council of the EU, 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ L 276/33, 20 Oct 2010.
51. EU Commission, 2011. Commission recommendation on the definition of nanomaterial. OJ L 275/38, 18 October 2011.
52. Evans D.F., Wennerström H. The Colloidal Domain: Where Physics, Chemistry, Biology, and Technology Meet 1999, John Wiley and Sons Inc., Hoboken NJ, USA, p. 672 (ISBN: 978-0-471-24247-5). 2nd ed.
53. Fabian E., Landsiedel R., Ma-Hock L., Wiench K., Wohlleben W., van Ravenzwaay B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 2008, 82(3):151-157.
54. Fairhurst D., Prescott S. The use of nuclear magnetic resonance as an analytical tool in the characterization of dispersion behavior. Spectrosc. Eur. 2011, 23(4):13-16.
55. Fruijtier-Polloth C. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. Toxicology 2012, 294:61-79.
56. Gamble J.F. Crystalline silica and Lung cancer: a critical review of the occupational epidemiology literature of exposure-response studies testing this hypothesis. Crit. Rev. Toxicol. 2011, 41:404-465.
57. Gamer A.O., Leibold E., van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol. In Vitro 2006, 20:301-307.
58. Gantzsch S.P., Kann B., Ofer-Glaessgen M., Loos P., Berchtold H., Balbach S., Eichinger T., Lehr C.-M., Schaefer U.F., Windbergs M. Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing. J. Control. Release 2014, 175:79-86.
59. Gebel T. Small difference in carcinogenic potency between GBP nanomaterials and GBP micromaterials. Arch. Toxicol. 2012, 86(7):995-1007.
60. Gebel T., Foth H., Damm G., Freyberger A., Kramer P.-J., Lilienblum W., Röhl C., Schupp T., Weiss C., Wollin K.-M., Hengstler J.G. Manufactured nanomaterials: categorization and approaches to hazard assessment. Arch. Toxicol. 2014, 88:2191-2211.
61. Geraets L., Oomen A.G., Schroeter J.D., Coleman V.A., Cassee F.R. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol. Sci. 2012, 127:463-473.
62. Ging J., Tejerina-Anton R., Ramakrishnan G., Nielsen M., Murphy K., Gorham J.M., Nguyen T., Orlov A. Development of a conceptual framework for evaluation of nanomaterials release from nanocomposites: environmental and toxicological implications. Sci. Total Environ. 2014, 473-474:9-19.
63. Golbamaki N., Rasulev B., Cassano A., Robinson R.L.M., Benfenati E., Leszczynski J., Cronin M.T. Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms. Nanoscale 2015, 7(6):2154-2198.
64. Gordon S.C., Butala J.H., Carter J.M., Elder A., Gordon T., Gray G., Sayre P.G., Schulte P.A., Tsai C.S., West J. Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials. Regul. Toxicol. Pharmacol. 2014, 68(3):305-311.
65. Grieger K.D., Redmon J.H., Money E.S., Widder M.W., van der Schalie W.H., Beaulieu S.M., Womack D. A relative ranking approach for nano-enabled applications to improve risk-based decision making: a case study of Army materiel. Environ. Syst. Decis. 2014, (epub ahead of print 24 Dec 2014, doi: 10.1007/s10669-014-9531-4).
66. Grosse Y., Loomis D., Guyton K.Z., Lauby-Secretan B., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Scoccianti C., Mattock H., Straif K. International agency for research on cancer monograph working group. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol. 2014, 15:1427-1428.
67. Guadagnini R., Halamoda Kenzaoui B., Cartwright L., Pojana G., Magdolenova Z., Bilanicova D., Saunders M., Juillerat L., Marcomini A., Huk A., Dusinska M., Fjellsbø L.M., Marano F., Boland S. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 2013, (epub ahead of print 27Jul 2013, doi:10.3109/17435390.2013.829590. (09 Mar 2015: still only online)).
68. 2 and silver nanomaterials. Mutat. Res. 2015, (submitted for publication).
69. Hellack, B., Hulser, T., Izak, E., Kuhlbusch, T., Meyer, F., Spree, M., Voetz, M., Wiggers, H., Wohlleben, W., 2013. Characterization of all nanoGEM materials. http://www.nanogem.de/cms/nanogem/upload/Veroeffentlichungen/nano-GEM_Del1.3.1_Characterization_Materials_2013_04_24.pdf.
70. Hesterberg T.W., Miller W.C., Musselman R.P., Kamstrup O., Hamilton R.D., Thevenaz P. Biopersistence of man-made vitreous fibers and crocidolite asbestos in the rat lung following inhalation. Fundam. Appl. Toxicol. 1996, 29:267-279.
71. Hittinger M., Juntke J., Kletting S., Schneider-Daum N., de Souza Carvalho C., Lehr C.-M. Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models. Adv. Drug Deliv. Rev. 2014, 10.1016/j.addr.2014.10.011.
72. Hristozov D.R., Gottardo S., Critto A., Marcomini A. Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective. Nanotoxicology 2012, 6:880-898.
73. Hsieh S.F., Bello D., Schmidt D.F., Pal A.K., Stella A., Isaacs J.A., Rogers E.J. Mapping the biological oxidative damage of engineered nanomaterials. Small 2013, 9(9-10):1853-1865.
74. Hühn D., Kantner K., Geidel C., Brandholt S., De Cock I., Soenen S.J., Rivera Gil P., Montenegro J.M., Braeckmans K., Müllen K., Nienhaus G.U., Klapper M., Parak W.J. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 2013, 7(4):3253-3263.
75. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans 2010, vol. 93. IARC, IARC, Lyon, France, pp. 166-171.
76. ICRP Publication No. 66: Human respiratory tract model for radiological protection. Ann. ICRP 1994, 24:1-3. ICRP (International Commission on Radiological Protection).
77. Izak-Nau E., Voetz M. As-produced: intrinsic physico-chemical properties and appropriate characterization tools. Safety of Nanomaterials Along their Lifecycle: Release, Exposure, and Human Hazards 2014, 3-23. CRC Press, London, UK, ISBN 978-1-46-656786-3. W. Wohlleben, T.A.J. Kuhlbusch, C.-M. Lehr, J. Schnekenburger (Eds.).
78. Johnston H.J., Pojana G., Zuin S., Jacobsen N.R., Møller P., Loft S., Semmler-Behnke M., McGuiness C., Balharry D., Marcomini A., Wallin H., Kreyling W., Donaldson K., Tran L., Stone V. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit. Rev. Toxicol. 2013, 43:1-20.
79. Kaiser J.P., Roesslein M., Diener L., Wick P. Human health risk of ingested nanoparticles that are added as multifunctional agents to paints: an in vitro study. PLoS One 2013, 8(12):e83215.
80. Keene A.M., Tyner K.M. Analytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregates. J. Nanopart. Res. 2011, 13:3465-3481.
81. Keene A.M., Bancos S., Tyner K.M. Considerations for In Vitro Nanotoxicity Testing. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology 2014, John Wiley & Sons Ltd, Chichester, UK.
82. Keller J., Wohlleben W., Ma-Hock L., Groeters S., Küttler K., Strauss V., Wiench K.E., Herden C., Oberdörster G., van Ravenzwaay B., Landsiedel R. Time-course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch. Toxicol. 2014, 88:2033-2059.
83. Kettler K., Veltman K., van de Meent D., van Wezel A., Hendriks A.J. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ. Toxicol. Chem. 2014, 33(3):481-492.
84. Kim Y., Klutz A.M., Jacobson K.A. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjug. Chem. 2008, 19(8):1660-1672.
85. Kim S.T., Saha K., Kim C., Rotello V.M. The role of surface functionality in determining nanoparticle cytotoxicity. Acc. Chem. Res. 2013, 46(3):681-691.
86. Kingston C., Zepp R., Andrady A., Boverhof D., Fehir R., Hawkins D., Wohlleben W. Release characteristics of selected carbon nanotube polymer composites. Carbon 2014, 68:33-57.
87. Klein C.L., Wiench K., Wiemann M., Ma-Hock L., van Ravenzwaay B., Landsiedel R. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch. Toxicol. 2012, 86(7):1137-1151.
88. Konduru N., Keller J., Ma-Hock L., Gröters S., Landsiedel R., Donaghey T.C., Brain J.D., Wohlleben W., Molina R.M. Biokinetics and effects of barium sulfate nanoparticles. Part. Fibre Toxicol. 2014, 11:55.
89. Kong B., Seog J.H., Graham L.M., Lee S.B. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine 2011, 6(5):929-941.
90. Kreyling W.G., Semmler-Behnke M., Takenaka S., Möller W. Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc. Chem. Res. 2013, 46(3):714-722.
91. Kreyling W.G., Hirn S., Möller W., Schleh C., Wenk A., Celik G., Lipka J., Schäffler M., Haberl N., Johnston B.D., Sperling R., Schmid G., Simon U., Parak W.J., Semmler-Behnke M. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano 2014, 8(1):222-233.
92. Kroll A., Dierker C., Rommel C., Hahn D., Wohlleben W., Schulze-Isfort C., Göbbert C., Voetz M., Hardinghaus F., Schnekenburger J. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part. Fibre Toxicol. 2011, 8(1):1-19.
93. Krug H.F. Nanosafety research - are we on the right track?. Angew. Chem. Int. Ed. 2014, 53(46):12304-12319.
94. Kuempel E.D., Castranova V., Geraci C.L., Schulte P.A. Development of risk-based nanomaterial groups for occupational exposure control. J. Nanopart. Res. 2012, 14:1029.
95. Kuempel E.D., Attfield M.D., Stayner L.T., Castranova V. Human and animal evidence supports lower occupational exposure limits for poorly-soluble respirable particles. Letter to the editor in respect to: low-toxicity dusts: current exposure guidelines are not sufficiently protective, by Cherrie, Brosseau, Hay and Donaldson. Ann. Occup. Hyg. 2014, 58(9):1205-1208.
96. Kuhlbusch T.A.J., Canady R. Case study: the life cycle of conductive plastics based on MWCNTs. Safety of Nanomaterials along their Lifecycle: Release, Exposure, and Human Hazards 2014, CRC Press, London, UK, Ch. 18. W. Wohlleben, T.A.J. Kuhlbusch, C.-M. Lehr, J. Schnekenburger (Eds.).
97. Landsiedel R., Kapp M.D., Schulz M., Wiench K., Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations - many questions, some answers. Mutat. Res. 2009, 681(2-3):241-258.
98. Landsiedel R., Ma-Hock L., Kroll A., Hahn D., Schnekenburger J., Wiench K., Wohlleben W. Testing metal-oxide nanomaterials for human safety. Adv. Mater. 2010, 22:2601-2627.
99. Landsiedel R., Fabian E., Ma-Hock L., Wohlleben W., Wiench K., Oesch F., van Ravenzwaay B. Toxico-/biokinetics of nanomaterials. Arch. Toxicol. 2012, 86:1021-1060.
100. Landsiedel R., Sauer U.G., Ma-Hock L., Schnekenburger J., Wiemann M. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine 2014, 9(16):2557-2585.
101. Landsiedel R., Ma-Hock L., Hofmann T., Wiemann M., Strauss V., Treumann S., Wohlleben W., Gröters S., Wiench K., van Ravenzwaay B. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part. Fibre Toxicol. 2014, 11:16.
102. Lankveld D.P.K., Oomen A., Krystek P., Troost-De Jong A., Noorlander C.W., Van Eijkeren J.C.H., Geertsma R.E., De Jong W.H. The kinetics of the tissue distribution of silver nanoparticles of differents sizes. Biomaterials 2010, 31:8350-8361.
103. Li R., Ji Z., Chang C.H., Dunphy D.R., Cai X., Meng H., Zhang H., Sun B., Wang X., Dong J., Lin S., Wang M., Liao Y.P., Brinker C.J., Nel A., Xia T. Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design. ACS Nano 2014, 8:1771-1783.
104. Ma-Hock L., Burkhardt S., Strauss V., Gamer A.O., Wiench K., van Ravenzwaay B., Landsiedel R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 2009, 21:102-118.
105. Ma-Hock L., Treumann S., Strauss V., Brill S., Luizi F., Mertler M., Wiench K., Gamer A.O., van Ravenzwaay B., Landsiedel R. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3months. Toxicol. Sci. 2009, 112:468-481.
106. Ma-Hock L., Strauss V., Treumann S., Küttler K., Wohlleben W., Hofmann T., Gröters S., Wiench K., van Ravenzwaay B., Landsiedel R. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part. Fibre Toxicol. 2013, 10:23.
107. Ma-Hock L., Hofmann T., Landsiedel R., van Ravenzwaay B. A short-term inhalation study protocol: designed for testing of toxicity and fate of nanomaterials. Methods Mol. Biol. 2014, 1199:207-212.
108. Mattix B., Moore T., Uvarov O., Pollard S., O'Donnell L., Park K., Horne D., Dhulekar J., Reese L., Nguyen D., Kraveka J., Burg K., Alexis F. Effects of polymeric nanoparticle surface properties on interaction with brain tumor environment. Nano Life 2013, 3(4):1343003.
109. Meng H., Xia T., George S., Nel A.E. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 2009, 3:1620-1627.
110. Misra S.K., Dybowska A., Berhanu D., Luoma S.N., Valsami-Jones E. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies. Sci. Total Environ. 2012, 438:225-232.
111. Moghadam B.Y., Hou W.C., Corredor C., Westerhoff P., Posner J.D. The role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir 2012, 28(47):16318-16326.
112. Molina R.M., Konduru N.V., Jimenez R.J., Wohlleben W., Brain J.D. Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium. Environ. Sci. Nano 2014, 1:561.
113. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133(8):2525-2534.
114. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
115. Monteiro-Riviere N.A., Wiench K., Landsiedel R., Schulte S., Inman A.O., Riviere J.E. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol. Sci. 2011, 123(1):264-280.
116. Moreno-Horn M., Gebel T. Granular biodurable nanomaterials: no convincing evidence for systemic toxicity. Crit. Rev. Toxicol. 2014, 44(10):849-875.
117. Morfeld P., Treumann S., Ma-Hock L., Bruch J., Landsiedel R. Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100nm (nanoscale) and the slicing bias of transmission electron microscopy. Inhal. Toxicol. 2012, 24(14):939-951. (Erratum in: Inhal. Toxicol. 25(5), 307 (2013)).
118. Morrow P.E. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol. 1988, 10(3):369-384.
119. Morrow P.E. Mechanisms and significance of "particle overload". Toxic and Carcinogenic Effects of Solid Particles in the Respiratory Tract: Proceedings of the 4th International Inhalation Symposium, March 1993 in Hannover, Germany 1994, 17-25. International Life Sciences Institute Press, Washington DC, USA.
120. Morrow P.E., Haseman J.K., Hobbs C.H., Driscoll K.E., Vera V., Oberdörster G. The maximum tolerated dose for inhalation bioassays: toxicity vs. overload. Fundam. Appl. Toxicol. 1996, 29(2):155-167.
121. Murgia X., de Souza Carvalho C., Lehr C.-M. Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics. Eur. J. Nanomed. 2014, 6(3):157-169.
122. NANO SUPPORT Project, 2012. Scientific technical support on assessment of nanomaterials in REACH registration dossiers and adequacy of available information. AA No. 07.0307/2010/581080/AA/D3 between DG Environment (DG ENV) and the Joint Research Centre (JRC). Final Report on analysis and assessment (Task I, step 3&4&5) and options for adapting REACH (Task II, step 1), Frans M. Christensen (JRC Technical Responsible) Nanosafety & Regulatory Methods Competence Group I.04 Nanobiosciences Unit JRC-IHCP, addressed to DG ENV D.3 Attn.: Mr. H. Laursen (ENV D.3 Technical Responsible), Ref. Ares(2012)314828, 16 Mar 2012, http://ec.europa.eu/environment/chemicals/nanotech/pdf/jrc_report.pdf.
123. National Research Council Research Progress on Environmental, Health, and Safety Aspects of Engineered Nanomaterials 2013, National Academies Press, Washington, D.C.
124. Nel A.E., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
125. Nel A.E., Xia T., Meng H., Wang X., Lin S., Ji Z., Zhang H. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc. Chem. Res. 2013, 46(3):607-621.
126. Nikula K.J., Avila K.J., Griffith W.C., Mauderly J.L. Lung tissue responses and sites of particle retention differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fundam. Appl. Toxicol. 1997, 37:37-53.
127. Nikula K.J., Vallyathan V., Green F.H., Hahn F.F. Influence of exposure concentrations or dose on the distribution of particulate material in rat and human lungs. Environ. Health Perspect. 2001, 109:311-318.
128. Nowack B., David R.M., Fissan H., Morris H., Shatkin J.A., Stintz M., Zepp R., Brouwer D. Potential release scenarios for carbon nanotubes used in composites. Environ. Int. 2013, 59:1-11.
129. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8. ILSI Research Foundation.
130. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Int. Med. 2009, 267(1):89-105.
131. OECD, 2012. Guidance on sample preparation and dosimetry for the safety testing of manufactured nanomaterials. Series on the safety of manufactured nanomaterials. No. 36. ENV/JM/MONO(2012) 40, OECD, Paris, France, 18 Dec 2012.
132. OECD, 2014a. Guidance on grouping of chemicals, second edition. Series on testing and assessment No. 194. ENV/JM/MONO(2014) 4, OECD, Paris, France, 14 Apr 2014.
133. OECD, 2014b. Report of the OECD expert meeting on the physical chemical properties of manufactured nanomaterials and test guidelines. OECD Environment, Health, and Safety Publications. Series on the safety of manufactured nanomaterials. No. 41. ENV/JM/MONO(2014) 15, OECD, Paris, France, 4 Jul 2014.
134. Oomen A.G., Bos P.M.J., Fernandes T.F., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., van der Kammer F., Kühnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment -Report of the NanoSafety Cluster Working Group 10. Nanotoxicology 2014, 8:334-348.
135. Oomen A., Bos P.M.J., Landsiedel R. Concern-driven safety assessment of nanomaterials: an integrated approach using material properties, hazard, biokinetic and exposure data and considerations on grouping and read-across. Safety of Nanomaterials along their Lifecycle: Release, Exposure, and Human Hazards 2014, CRC Press, London, UK, (Ch. 16). W. Wohlleben, T.A.J. Kuhlbusch, C.-M. Lehr, J. Schnekenburger (Eds.).
136. Pastoor T.P., Bachman A.N., Bell D.R., Cohen S.M., Dellarco M., Dewhurst I.C., Doe J.E., Doerrer N.G., Embry M.R., Hines R.N., Moretto A., Phillips R.D., Rowlands J.C., Tanir J.Y., Wolf D.C., Boobis A.R. A 21st century roadmap for human health risk assessment. Crit. Rev. Toxicol. 2014, 44(Suppl. 3):1-5.
137. Patil S., Sandberg A., Heckert E., Self W., Seal S. Protein absorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 2007, 28(31):4600-4607.
138. Patlewicz G., Ball N., Booth E.D., Hulzebos E., Zvinavashe E., Hennes C. Use of category approaches, read-across and (Q)SAR: general considerations. Regul. Toxicol. Pharmacol. 2013, 67:1-12.
139. Pauluhn J. Derivation of occupational exposure levels (OELs) of low-toxicity isometric biopersistent particles: how can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation?. Part. Fibre Toxicol. 2014, 11(1):72.
140. Pavan C., Rabolli V., Tomatis M., Fubini B., Lison D. Why does the hemolytic activity of silica predict its pro-inflammatory activity?. Part. Fibre Toxicol. 2014, 11(1):76.
141. Pietruska J.R., Liu X., Smith A., McNeil K., Weston P., Zhitkovich A., Hurt R., Kane A.B. Bioavailability, intracellular mobilization of nickel, and HIF-1a activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles. Toxicol. Sci. 2011, 124(1):138-148.
142. Poland C.A., Duffin R., Donaldson K. High aspect nanoparticles and the fibre pathogenicity paradigm. Nanotoxcity: From In Vivo and In Vitro Models to Health Risks 2009, Wiley-VCH Verlag GmbH, Weinheim, Germany, Chapter 4. S.C. Sahu, D.A. Casciano (Eds.).
143. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 2006, 90(2):296-303.
144. Pujalté I., Passagne I., Dalculsi R., de Portal C., Ohayon-Courtès C., L'Azou B. Cytotoxic effectsand cellular oxidative mechanisms of metallic nanoparticles on renal tubular cells: impact of particle solubility. Toxicol. Res. 2014, (epub ahead of print 23 Dec 2014, doi: 10.1039/C4TX00184B).
145. RPA, IVAM, 2014. RPA - Risk and Policy Analysts Ltd., UK; IVAM - Research and Consultancy on Sustainability, University of Amsterdam, NL. Guidance on the protection of the health and safety of workers from the potential risks related to nanomaterials at work. COM 2.4, June 2014. Publication commissioned by the European Union Programme for Employment and Social Solidarity - PROGRESS (2007-2013).
146. Rushton E.K., Jiang J., Leonard S.S., Eberly S., Castranova V., Biswas P., Elder A., Han X., Gelein R., Finkelstein J., Oberdörster G. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J. Toxicol. Environ. Health A 2010, 73(5):445-461.
147. Saber A.T., Jacobsen N.R., Mortensen A., Szarek J., Jackson P., Madsen A.M., Jensen K.A., Koponen I.K., Brunborg G., Gützkow K.B., Vogel U., Wallin H. Nanotitanium dioxide toxicity in mouse lung is reduced in sanding dust from paint. Part. Fibre Toxicol. 2012, 9:4.
148. Saber A.T., Jensen K.A. Case study: paints and lacquers with silica nanoparticles. Safety of Nanomaterials along their Lifecycle: Release, Exposure, and Human Hazards 2014, CRC Press, London, UK, Ch. 17. W. Wohlleben, T.A.J. Kuhlbusch, C.-M. Lehr, J. Schnekenburger (Eds.).
149. 2 particles. Toxicol. Sci. 2010, 115(1):156-166.
150. Salomon J.J., Muchitsch V.E., Gausterer J.C., Schwagerus E., Huwer H., Daum N., Lehr C.-M., Ehrhardt C. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. Mol. Pharm. 2014, 11(3):995-1006.
151. Sauer U.G., Vogel S., Aumann A., Hess A., Kolle S.N., Ma-Hock L., Wohlleben W., Dammann M., Strauss V., Treumann S., Gröters S., Wiench K., van Ravenzwaay B., Landsiedel R. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. Toxicol. Appl. Pharmacol. 2014, 276:1-20.
152. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97(1):163-180.
153. SCCS, 2014. Scientific Committee on Consumer Safety. Opinion for clarification of the meaning of the term "sprayable applications/products" for the nano forms of Carbon Black CI 77266, Titanium Oxide and Zinc Oxide. Adopted at the 7th SCCS plenary meeting 23 Sept 2014. SCCS/1539/14, rev. of 16 Dec 2014, p. 13.
154. SCENIHR, 2015. The Scientific Committee on Emerging and Newly Identified Health Risks. Opinion on the guidance on the determination of potential health effects of nanomaterials used in medical devices. 6 Jan 2015.
155. Semmler-Behnke M., Takenaka S., Fertsch S., Wenk A., Seitz J., Mayer P., Oberdörster G., Kreyling W.G. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ. Health Perspect. 2007, 115(5):728-733.
156. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., Schmid G., Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4(12):2108-2111.
157. Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schäffler M., Tian F., Schmid G., Oberdörster G., Kreyling W.G. Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat. Part. Fibre Toxicol. 2014, 11:33.
158. Sharma A., Madhunapantula S.V., Roberson G.P. Toxicological considerations when creating nanoparticle based drugs and drug delivery systems?. Expert Opin. Drug Metab. Toxicol. 2012, 8(1):47-69.
159. Silva R.M., Doudrick K., Franzi L.M., TeeSy C., Anderson D.S., Wu Z., Mitra S., Vu V., Dutrow G., Evans J.E., Westerhoff P., van Winkle L.S., Raabe O.G., Pinkerton K.E. Instillation versus inhalation of multiwalled carbon nanotubes: exposure-related health effects, clearance, and the role of particle characteristics. ACS Nano 2014, 8(9):8911-8931.
160. Singh N.B., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., Wright C.J. Nanogenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
161. Smulders S., Luyts K., Brabants G., Landuyt K.V., Kirschhock C., Smolders E., Golanski L., Vanoirbeek J., Hoet P.H. Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice. Toxicol. Sci. 2014, 141(1):132-140.
162. Stefaniak A.B., Guilmette R.A., Day G.A., Hoover M.D., Breysse P.N., Scripsick R.C. Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution. Toxicol. In Vitro 2005, 19:123-134.
163. Stefaniak A.B., Hackley V.A., Roebben G., Ehara K., Hankin S., Postek M.T., Lynch I., Fu W.E., Linsinger T.P., Thünemann A.F. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 2013, 7(8):1325-1337.
164. Stone V., Johnston H., Schins R.P.F. Development of in vitro systems for nanotoxicology: methodological considerations. Crit. Rev. Toxicol. 2009, 39:613-626.
165. Stone V., Pozzi-Mucelli S., Tran L., Aschberger K., Sabella S., Vogel U.B., Poland C., Balharry D., Fernandes T., Gottardo S., Hankin S., Hartl M.G., Hartmann N., Hristozov D., Hund-Rinke K., Johnston H., Marcomini A., Panzer O., Roncato D., Saber A.T., Wallin H., Scott-Fordsmand J.J. ITS-NANO - prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part. Fibre Toxicol. 2014, 11:9.
166. Sullivan L.H. The Tall Office Building Artistically Considered 1896, Lippincott's Magazine, pp. 403-409.
167. Suzuki, N., 2003. X-ray photoelectron spectroscopy and its application to carbon. Carbon Alloys: Novel Concepts Develop Carbon Sci. Technol. 211-222.
168. Tarantini A., Lanceleur R., Mourot A., Lavault M.T., Casterou G., Jarry G., Hogeveen K., Fessard V. Toxicity, genotoxicity and proinflammatory effects of amorphous nanosilica in the human intestinal Caco-2 cell line. Toxicol. In Vitro 2014, (epub ahead of print 13 Nov 2014, doi: 10.1016/j.tiv.2014.10.023).
169. Tarantini A., Huet S., Jarry G., Lanceleur R., Poul M., Tavares A., Vital N., Louro H., João Silva M., Fessard V. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 1: oral route. Environ. Mol. Mutagen. 2014, (epub ahead of print 15 Dec 2014, doi: 10.1002/em.21935).
170. Taurozzi J.S., Hackley V.A., Wiesner M.R. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment - issues and recommendations. Nanotoxicology 2010, 5:711-729.
171. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95:212-300. (Erratum in: Toxicol. Sci. 97, 614).
172. Tollefsen K.E., Scholz S., Cronin M.T., Edwards S.W., de Knecht J., Crofton K., Garcia-Reyero N., Hartung T., Worth A., Patlewicz G. Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul. Toxicol. Pharmacol. 2014, 70(3):629-640.
173. UBA, 2014. Umweltbundesamt - Federal Environmental Agency. - Assessment of impacts of a European register of products containing nanomaterials. Texte 23/2014. In: Herman, A., Diesner, M.O., Abel, J., Hawthorne, C., Greßmann, A. (Eds.), Project No. (FKZ) 360 01 072, Report No. (UBA-FB) 001907/E, 142 p.
174. Van der Zande M., Vandebriel R.J., van Doren E., Kramer E., Herrera Rivera Z., Serrano-Rojero C.S., Gremmer E.R., Mast J., Peters R.J.B., Hollman P.C.H., Hendriksen P.J.M., Marvin H.J.P., Peijnenburg A.A.C.M., Bouwmeester H. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6(8):7427-7442.
175. Van der Zande M., Vandebriel R.J., Groot M.J., Kramer E., Rivera Z.H., Rasmussen K., Ossenkoppele J.S., Tromp P., Gremmer E.R., Peters R.J.B., Hendriksen P.J., Marvin H.J.P., Peijnenburg A.A.C.M., Bouwmeester H. Sub-chronic toxicity study in rats orally exposed to nanostructured silica. Part. Fibre Toxicol. 2014, 11:8.
176. 2 and quartz. Toxicol. Lett. 2009, 186:152-159.
177. Visalli G., Bertuccio M.P., Iannazzo D., Piperno A., Pistone A., Di Pietro A. Toxicological assessment of multi-walled carbon nanotubes on A549 human lung epithelial cells. Toxicol. In Vitro 2015, 29(2):352-362.
178. Wagner S., Gondikas A., Neubauer E., Hofmann T., von der Kammer F. Spot the difference: Engineered and natural nanoparticles in the environment-release, behavior, and fate - Finde den Unterschied: synthetische und natürliche Nanopartikel in der Umwelt - Freisetzung, Verhalten und Verbleib. Angew. Chem. 2014, 126:12604-12626.
179. Walser T., Limbach L.K., Brogioli R., Erismann E., Flamigni L., Hattendorf B., Juchli M., Krumeich F., Ludwig C., Prikopsky K., Rossier M., Saner D., Sigg A., Hellweg S., Günther D., Stark W.J. Persistence of engineered nanoparticles in a municipal solid-waste incineration plant. Nat. Nanotechnol. 2012, 7:520-524.
180. Wang, A., Berg, E.L., Polokoff, M., Yang, J., El-Badawy, A., Reif, D., Kleinstreuer, N., Marinakos, S., Badireddy, A.R., Gavett, S., Rotroff, D., Gangwal, S., Rabinowitz, J., Matson, C., Tolavma, T., Wiesner, M., Houck, K., 2013. Ranking and profiling nanomaterial (NM) bioactivity by ToxCast high-throughput screening (HTS). In: Poster at the 52nd Annual Meeting of the Society of Toxicology (SOT), 10-14 Mar 2013.
181. 2 nanoparticles depends on their structural features: size, shape, crystal phases, and surface coating. Int. J. Mol. Sci. 2014, 15(12):22258-22278.
182. Wang X.Z., Yang Y., Li R., McGuinnes C., Adamson J., Megson I.L., Donaldson K. Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles. Nanotoxicology 2014, 8(5):465-476.
183. 2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104.
184. Warheit D.B. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?. Toxicol. Sci. 2008, 101(2):183-185.
185. WHO, 2005. World Health Organization. Air quality guidelines for Europe, 2nd edition, http://www.euro.who.int/__data/assets/pdf_file/0005/74732/E71922.pdf.
186. Wiemann M., Bruch J. Comparison of in vitro and in vivo findings. NanoCare. Health Related Aspects of Nanomaterials. Final Scientific Report 2009, 68-73. Dechema, Frankfurt, Germany. T.K.J. Kuhlbusch, K. Nau, H. Krug (Eds.).
187. Wiemann, M., Vennemann, A., Bruch, J., Wiench, K., Ma-Hock, L., Landsiedel, R., 2015. Evaluation of a macrophage assay for predicting nanomaterial-induced inhalation toxicity. Manuscript in preparation.
188. Wiesner, M.R., 2014. Some thoughts on exposure. In: Presentation at the 4th International Conference on Safe Production and Use of Nanomaterials. 18-20 Nov 2014, Grenoble, France.
189. Wohlleben W., Brill S., Meier M.W., Mertler M., Cox G., Hirth S., von Vacano B., Strauss V., Treumann S., Wiench K., Ma-Hock L., Landsiedel R. On the lifecycle of nanocomposites: comparing released fragments and their in-vivo hazards from three release mechanisms and four nanocomposites. Small 2011, 7(16):2384-2395.
190. Wohlleben W., Ma-Hock L., Boyko V., Cox G., Egenolf H., Freiberger H., Hinrichsen B., Hirth S., Landsiedel R. Nanospecific guidance in REACH: a comparative physico-chemical characterization of 15 materials with methodical correlations. J. Ceram. Sci. Technol. 2013, 4:93-104.
191. Wohlleben W., Kuhlbusch T., Lehr C.-M., Schnekenburger J. Safety of Nanomaterials along their Lifecycle: Release, Exposure and Human Hazards 2014, CRC Press, London, UK.
192. Wohlleben W., Vilar G., Fernández-Rosas E., González-Gálvez D., Gabriel C., Hirth S., Vazquez-Campos S. A pilot interlaboratory comparison of protocols that simulate aging of nanocomposites and detect released fragments. Environ. Chem. 2014, 11(4):402-418.
193. Xia X.R., Monteiro-Riviere N.A., Mathur S., Song X., Xiao L., Oldenberg S.J., Fadeel B., Riviere J.E. Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano 2011, 5(11):9074-9081.
194. Yang K., Gong H., Shi X., Wan J., Zhang Y., Liu Z. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 2013, 34(11):2787-2795.
195. Yi J., Chen B.T., Schwegler-Berry D., Frazer D., Castranova V., McBride C., Knuckles T.L., Stapleton P.A., Minarchick V.C., Nurkiewicz T.R. Whole-body nanoparticle aerosol inhalation exposures. J. Vis. Exp. 2013, 75:e50263.
196. Yokel R.A., Unrine J.M., Wu P., Wang B., Grulke E.A. Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shape. Environ. Sci. Nanotechnol. 2014, 1:549.
197. Zhang H., Ji Z., Xia T., Meng H., Low-Kam C., Liu R., Pokhrel S., Lin S., Wang X., Liao Y.-P., Wang M., Li L., Rallo R., Damoiseaux R., Telesca D., Mädler L., Cohen Y., Zink J.I., Nel A.E. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6(5):4349-4368.
198. Zhu M., Nie G., Meng H., Xia T., Nel A., Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport and fate. Acc. Chem. Res. 2013, 46(3):622-631.